A mesothelioma diagnosis and recurrence monitoring has many facets. Patients, when seeing their oncologists, may hear information about imaging, biopsies, pathology, and biomarkers and genetic analysis. These sessions will focus on each of these areas.
These sessions are presented by:
Christopher Straus, MD, University of Chicago
Andrea Wolf, MD, Mount Sinai
Jennifer Sauter, MD, Memorial Sloan Kettering Cancer Center
Raphael Bueno, MD, Brigham and Women’s Hospital
This is a recording of a session at the 2024 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Merck; The Gori Law Firm; Bristol Myers Squibb; Early Lucarelli Sweeney & Meisenkothen
Find other recorded sessions and more information at www.curemeso.org/symposium
